T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
News
The Evolving Arsenal Against Mosquito-Borne Diseases
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic…
10/09/2020 - 8 minutes
Investor Interest in Meat Alternative Biotechs Booms
In recent times, an unexpectedly large number of investments have closed in biotech startups offering…
08/09/2020 - 6 minutes
A Renaissance in Chronic Kidney Disease Treatment Is Underway
After years of drought, recent technological and clinical breakthroughs are causing research into chronic kidney…
03/09/2020 - 5 minutes
Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
01/09/2020 - 5 minutes
Can Covid-19 Vaccines Keep up with an Evolving Virus?
The first generation of vaccines for Covid-19 is edging closer to the market. But are…
27/08/2020 - 6 minutes
What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?
A drug developed by the US firm Unity Biotechnology -- designed to slow the aging…
25/08/2020 - 6 minutes
Is Hepatitis D Healthcare Being Overlooked?
Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains…
20/08/2020 - 4 minutes
Women’s Health Gains Traction as Bayer Pays €736M for UK Firm
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
18/08/2020 - 3 minutes
CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced…
17/08/2020 - 3 minutes
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
14/08/2020 - 5 minutes
Why are Some European Biotechs Going Public Without an IPO?
European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all…
13/08/2020 - 7 minutes
